Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2006
Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis
Bo Shen, Victor W Fazio, Feza H Remzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2015
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma
Fernando Doñate, Arthur Raitano, Kendall Morrison, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
ACS Medicinal Chemistry Letters
|
May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
Malcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Journal of Medicinal Chemistry
|
March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
Malcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors
Michael Siu, Richard Pastor, Wendy Liu, et al.
Cancer Research
|
March 26, 2016
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Pia M Challita-Eid, Daulet Satpayev, Peng Yang, et al.
Journal of Medicinal Chemistry
|
October 24, 2014
Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models
Snahel Patel, Frederick Cohen, Brian J Dean, et al.
Journal of Medicinal Chemistry
|
March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C
Nicholas F Endres, Steven Do, Rana Mroue, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2006
Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis
Bo Shen, Victor W Fazio, Feza H Remzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2015
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma
Fernando Doñate, Arthur Raitano, Kendall Morrison, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
ACS Medicinal Chemistry Letters
|
May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
Malcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Journal of Medicinal Chemistry
|
March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
Malcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors
Michael Siu, Richard Pastor, Wendy Liu, et al.
Cancer Research
|
March 26, 2016
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Pia M Challita-Eid, Daulet Satpayev, Peng Yang, et al.
Journal of Medicinal Chemistry
|
October 24, 2014
Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models
Snahel Patel, Frederick Cohen, Brian J Dean, et al.
Journal of Medicinal Chemistry
|
March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C
Nicholas F Endres, Steven Do, Rana Mroue, et al.
Page
of 7